Steven Nissen, head of cardiology at the Cleveland Clinic in Ohio, talks with Bloomberg's Allan Dodds Frank from Gaithersburg, Maryland, about today's vote by a U.S. Food and Drug Administration advisory panel about the safety of GlaxoSmithKline Plc's diabetes pill Avandia and the safety of Takeda Pharmaceutical Co.'s Actos. The panel decided that Avandia should remain on the market but be accompanied by new safety warnings. (Source: Bloomberg)